Inhibiting HSP90 simultaneously reduced various factors that promote hepatocarcinogenesis, suppressed the growth of HCC tumors, and induced apoptosis (Nouri-Vaskeh et al., 2020). This evidence concerns the gene HSP90AA1 and hepatocellular carcinoma.